Atlas FDA

ESSURE SYSTEM

FDA premarket approval P020014/S044 · decided 2016-05-12

Approval details

PMA number
P020014
Supplement
S044
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol - OSB
Trade name
ESSURE SYSTEM
Generic name
Transcervical contraceptive tubal occlusion device
Applicant
Bayer Pharma AG
Date received
2015-09-01
Decision date
2016-05-12
Days to decision
254 days
Decision code
APPR
Product code
HHS
Advisory committee
Obstetrics/Gynecology
Expedited review
No
Location
Berlin
Statement
Approval of changes to the post-approval study protocol.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.